TAM
DNA icon

Titleist Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Titleist Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,961
Closed -$304K – 305
2024
Q4 		$304K Sell
30,961
-22,070
-42% -$189K 0.04% 249
2024
Q3 		$432K Sell
53,031
-3,690
-7% -$37K 0.06% 187
2024
Q2 		$758K Sell
56,721
-8,269
-13% -$247K 0.11% 128
2024
Q1 		$3.02M Sell
64,990
-614
-0.9% -$31.8K 0.53% 52
2023
Q4 		$4.43M Buy
65,604
+1,266
+2% +$77.5K 0.82% 28
2023
Q3 		$4.66M Buy
64,338
+1,031
+2% +$82.4K 1.08% 24
2023
Q2 		$4.71M Buy
63,307
+917
+1% +$54.3K 1.05% 26
2023
Q1 		$3.32M Buy
+62,390
New +$3.95M 0.7% 32

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return